|
1
|
Chang JY, Senan S, Paul MA, Mehran RJ,
Louie AV, Balter P, Groen HJ, McRae SE, Widder J, Feng L, et al:
Stereotactic ablative radiotherapy versus lobectomy for operable
stage I non-small-cell lung cancer: A pooled analysis of two
randomised trials. Lancet Oncol. 16:630–637. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Renyi-Vamos F, Tovari J, Fillinger J,
Timar J, Paku S, Kenessey I, Ostoros G, Agocs L, Soltesz I and Dome
B: Lymphangiogenesis correlates with lymph node metastasis,
prognosis, and angiogenic phenotype in human non-small cell lung
cancer. Clin Cancer Res. 11:7344–7353. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kayser G: Non-small cell lung cancer. New
biomarkers for diagnostics and therapy. Pathologe. 36(Suppl 2):
S189–S193. 2015.(In German). View Article : Google Scholar
|
|
4
|
Chen J, Wang R, Zhang K and Chen LB: Long
non-coding RNAs in non-small cell lung cancer as biomarkers and
therapeutic targets. J Cell Mol Med. 18:2425–2436. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu T, Yin X, Zhou Y, Wang Z, Shen S, Qiu
Y, Sun R and Zhao Z: Roles of noncoding RNAs in metastasis of
nonsmall cell lung cancer: A mini review. J Cancer Res Ther.
11(Suppl 1): C7–C10. 2015.PubMed/NCBI
|
|
6
|
Mercer TR and Mattick JS: Structure and
function of long noncoding RNAs in epigenetic regulation. Nat
Struct Mol Biol. 20:300–307. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sang H, Liu H, Xiong P and Zhu M: Long
non-coding RNA functions in lung cancer. Tumour Biol. 36:4027–4037.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Loewen G, Jayawickramarajah J, Zhuo Y and
Shan B: Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol.
7:902014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo F, Guo L, Li Y, Zhou Q and Li Z:
MALAT1 is an oncogenic long non-coding RNA associated with tumor
invasion in non-small cell lung cancer regulated by DNA
methylation. Int J Clin Exp Pathol. 8:15903–15910. 2015.PubMed/NCBI
|
|
11
|
Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia
R, Liu YW, Liu XH, Zhang EB, Lu KH and Shu YQ: Long noncoding RNA
ANRIL promotes non-small cell lung cancer cell proliferation and
inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer
Ther. 14:268–277. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Unoki M, Daigo Y, Koinuma J, Tsuchiya E,
Hamamoto R and Nakamura Y: UHRF1 is a novel diagnostic marker of
lung cancer. Br J Cancer. 103:217–222. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jenkins Y, Markovtsov V, Lang W, Sharma P,
Pearsall D, Warner J, Franci C, Huang B, Huang J, Yam GC, et al:
Critical role of the ubiquitin ligase activity of UHRF1, a nuclear
RING finger protein, in tumor cell growth. Mol Biol Cell.
16:5621–5629. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bostick M, Kim JK, Estève PO, Clark A,
Pradhan S and Jacobsen SE: UHRF1 plays a role in maintaining DNA
methylation in mammalian cells. Science. 317:1760–1764. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sadler KC, Krahn KN, Gaur NA and Ukomadu
C: Liver growth in the embryo and during liver regeneration in
zebrafish requires the cell cycle regulator, uhrf1. Proc Natl Acad
Sci USA. 104:1570–1575. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Obata Y, Furusawa Y, Endo TA, Sharif J,
Takahashi D, Atarashi K, Nakayama M, Onawa S, Fujimura Y, Takahashi
M, et al: The epigenetic regulator Uhrf1 facilitates the
proliferation and maturation of colonic regulatory T cells. Nat
Immunol. 15:571–579. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Taniue K, Kurimoto A, Sugimasa H, Nasu E,
Takeda Y, Iwasaki K, Nagashima T, Okada-Hatakeyama M, Oyama M,
Kozuka-Hata H, et al: Long noncoding RNA UPAT promotes colon
tumorigenesis by inhibiting degradation of UHRF1. Proc Natl Acad
Sci USA. 113:1273–1278. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Daskalos A, Oleksiewicz U, Filia A,
Nikolaidis G, Xinarianos G, Gosney JR, Malliri A, Field JK and
Liloglou T: UHRF1-mediated tumor suppressor gene inactivation in
nonsmall cell lung cancer. Cancer. 117:1027–1037. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kontic M, Stojsic J, Jovanovic D,
Bunjevacki V, Ognjanovic S, Kuriger J, Puumala S and Nelson HH:
Aberrant promoter methylation of CDH13 and MGMT genes is associated
with clinicopathologic characteristics of primary non-small-cell
lung carcinoma. Clin Lung Cancer. 13:297–303. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee MG, Jeong SI, Ko KP, Park SK, Ryu BK,
Kim IY, Kim JK and Chi SG: RASSF1A directly antagonizes RhoA
activity through the assembly of a Smurf1-mediated destruction
complex to suppress tumorigenesis. Cancer Res. 76:1847–1859. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jeanblanc M, Mousli M, Hopfner R, Bathami
K, Martinet N, Abbady AQ, Siffert JC, Mathieu E, Muller CD and
Bronner C: The retinoblastoma gene and its product are targeted by
ICBP90: A key mechanism in the G1/S transition during the cell
cycle. Oncogene. 24:7337–7345. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Unoki M, Nishidate T and Nakamura Y:
ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG
through its SRA domain. Oncogene. 23:7601–7610. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Achour M, Jacq X, Rondé P, Alhosin M,
Charlot C, Chataigneau T, Jeanblanc M, Macaluso M, Giordano A,
Hughes AD, et al: The interaction of the SRA domain of ICBP90 with
a novel domain of DNMT1 is involved in the regulation of VEGF gene
expression. Oncogene. 27:2187–2197. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Karagianni P, Amazit L, Qin J and Wong J:
ICBP90, a novel methyl K9 H3 binding protein linking protein
ubiquitination with heterochromatin formation. Mol Cell Biol.
28:705–717. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Alhosin M, Sharif T, Mousli M,
Etienne-Selloum N, Fuhrmann G, Schini-Kerth VB and Bronner C:
Down-regulation of UHRF1, associated with re-expression of tumor
suppressor genes, is a common feature of natural compounds
exhibiting anti-cancer properties. J Exp Clin Cancer Res.
30:412011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Avvakumov GV, Walker JR, Xue S, Li Y, Duan
S, Bronner C, Arrowsmith CH and Dhe-Paganon S: Structural basis for
recognition of hemi-methylated DNA by the SRA domain of human
UHRF1. Nature. 455:822–825. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sharif J, Muto M, Takebayashi S, Suetake
I, Iwamatsu A, Endo TA, Shinga J, Mizutani-Koseki Y, Toyoda T,
Okamura K, et al: The SRA protein Np95 mediates epigenetic
inheritance by recruiting Dnmt1 to methylated DNA. Nature.
450:908–912. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Donninger H, Clark JA, Monaghan MK,
Schmidt ML, Vos M and Clark GJ: Cell cycle restriction is more
important than apoptosis induction for RASSF1A protein tumor
suppression. J Biol Chem. 289:31287–31295. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang ZY, Wu Y, Hedrick N and Gutmann DH:
T-cadherin-mediated cell growth regulation involves G2 phase arrest
and requires p21(CIP1/WAF1) expression. Mol Cell Biol. 23:566–578.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yanagawa N, Tamura G, Oizumi H, Kanauchi
N, Endoh M, Sadahiro M and Motoyama T: Promoter hypermethylation of
RASSF1A and RUNX3 genes as an independent prognostic prediction
marker in surgically resected non-small cell lung cancers. Lung
Cancer. 58:131–138. 2007. View Article : Google Scholar : PubMed/NCBI
|
